Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Practice-Level Variation in Molecular Testing and Use of Targeted Therapy for Patients With Non–Small Cell Lung Cancer and Colorectal Cancer
Thomas J. Roberts, Kenneth L. Kehl, Gabriel A. Brooks, et al.
JAMA Network Open (2023) Vol. 6, Iss. 4, pp. e2310809-e2310809
Open Access | Times Cited: 18

Showing 18 citing articles:

Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries
Vincent D. de Jager, Wim Timens, Arnaud Bayle, et al.
The Lancet Regional Health - Europe (2024) Vol. 38, pp. 100838-100838
Open Access | Times Cited: 24
The State of State Biomarker Testing Insurance Coverage Laws
Grace A. Lin, Janet M. Coffman, Kathryn A. Phillips
JAMA (2024) Vol. 331, Iss. 22, pp. 1885-1885
Closed Access | Times Cited: 6
The Impact of Prior Single-Gene Testing on Comprehensive Genomic Profiling Results for Patients with Non-Small Cell Lung Cancer
Mary Nesline, Vivek Subbiah, Rebecca A. Previs, et al.
Oncology and Therapy (2024) Vol. 12, Iss. 2, pp. 329-343
Open Access | Times Cited: 5
Comprehensive transcriptome, miRNA and kinome profiling identifies new treatment options for personalized lung cancer therapy
Shen Zhong, Yvonne Börgeling, Patrick Zardo, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 3
Open Access
Racial and ethnic disparities in genomic testing among lung cancer patients: a systematic review
Clare Meernik, Yadurshini Raveendran, Michala Kolarova, et al.
JNCI Journal of the National Cancer Institute (2024) Vol. 116, Iss. 6, pp. 812-828
Closed Access | Times Cited: 3
Barriers and facilitators to next-generation sequencing use in United States oncology settings: a systematic review
Andrea Ferreira‐Gonzalez, Gilbert Ko, Nicole Fusco, et al.
Future Oncology (2024), pp. 1-13
Open Access | Times Cited: 3
NSCLC Digital PCR Panel Returns Low-Input Sample Results Where Sequencing Fails
Leah Herdt, Paige Berroteran, Malini Rajagopalan, et al.
Diagnostics (2024) Vol. 14, Iss. 3, pp. 243-243
Open Access | Times Cited: 2
Genetic alterations predict poor efficacy, outcomes and resistance to second-line osimertinib treatment in non-small cell lung cancer
Hao Bai
American Journal of Cancer Research (2024) Vol. 14, Iss. 1, pp. 33-51
Open Access | Times Cited: 2
Disparity of the Treatment of Unresectable Non-small Cell Lung Cancer Regarding Chemotherapy: A Systematic Review and Meta-Analysis
Ryuichi Ohta, Chiaki Sano
Cureus (2024)
Open Access | Times Cited: 2
Standardized and simplified reporting of next-generation sequencing results in advanced non-small-cell lung cancer: Practical indications from an Italian multidisciplinary group
Umberto Malapelle, Alessandro Delle Donne, Fabio Pagni, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 193, pp. 104217-104217
Open Access | Times Cited: 5
A graphSAGE discovers synergistic combinations of Gefitinib, paclitaxel, and Icotinib for Lung adenocarcinoma management by targeting human genes and proteins: the RAIN protocol
Sogand Sadeghi, Ali A. Kiaei, Mahnaz Boush, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Deficits of Molecular Prognosis/Diagnosis Studies in Underserved Populations
Arielle J. Medford, Beverly Moy
JCO Oncology Practice (2024) Vol. 20, Iss. 11, pp. 1515-1522
Closed Access | Times Cited: 1
Comprehensive transcriptome, miRNA and kinome profiling and its clinical translation for personalized lung cancer therapy
Shen Zhong, Yvonne Börgeling, Patrick Zardo, et al.
Research Square (Research Square) (2024)
Open Access
Using Artificial Intelligence to Support Informed Decision-Making on BRAF Mutation Testing
Jennifer Webster, Jennifer Ghith, Orion Penner, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access
Quality Measurement in Oncology: Time to Take the Next Step!
Ronald M. Kline, Dora L. Hughes, Michelle Schreiber
JCO Oncology Practice (2024)
Closed Access
Identification and treatment of lung cancer oncogenic drivers in a diverse safety net setting
Kalyani Narra, Bassam Ghabach, Vivek Athipatla, et al.
Clinical Lung Cancer (2024)
Closed Access
Realizing the Dream of Precision Oncology
Yaolin Zhou
Journal of Molecular Diagnostics (2023) Vol. 25, Iss. 12, pp. 851-856
Closed Access
Molecular Testing in Lung Cancer
Alain Borczuk
Surgical pathology clinics (2023) Vol. 17, Iss. 2, pp. 307-320
Closed Access
Page 1

Scroll to top